Drug and device developer now out to change how we do it with tech @meetclora

Cambridge, MA
Join me on the @Biotech2050Pod podcast with Kristin Yarema, President & CEO of @PoseidaThera. We discuss corporate culture, Allogeneic CAR-T therapies, and bridging the gap between physicians’ visions for medicine and investor priorities.
🔥 Host @rahulc explores bold biotech breakthroughs with Kristin Yarema, President & CEO of @PoseidaThera. From redefining cell therapy to inspiring leadership insights, this is a must-listen on the future of medicine! 🎧 on.soundcloud.com/g8drxxB8BH… #Biotech2050 #CellTherapy
4
215
Join me on the @Biotech2050Pod podcast with Bharatt Chowrira & @EricElenko of @PureTechH. We dive into their model for tackling big problems, the founding of @KarunaTx, and the benefits of evergreen funding.
Dive into the latest #Biotech2050 episode! Host @rahulc joins Bharatt Chowrira, CEO & @EricElenko, Co-Founder & President of @PureTechH as they share lessons on innovative R&D, tackling challenges, & Karuna Therapeutics' journey. Listen: on.soundcloud.com/qM5bpRmzwU… #Biotech #Podcast
4
137
I spoke with Abe Ceesay, CEO of Rapport Therapeutics, on what it takes to scale talent, lead with a servant mindset, and drive smart risk-taking in biotech. Hear his take on building emotional safety and more.
✨ Ready for the future of precision neuroscience? Abe Ceesay, CEO of Rapport Therapeutics, & #Biotech2050 host @rahulc dive into treatments for neurological disorders like focal epilepsy. Don’t miss these insights! Listen: on.soundcloud.com/bfTa3VLAE4… #PrecisionNeuroscience #biotech
3
197
Had a great conversation with @dave_bearss, CEO of @Halia_Tx, about the founding of the company, how their initial focus on the APOE4 gene led them to focus on inflammation, and their non-traditional financing strategy for clinical stage assets. Tune in.
Don't miss this #Biotech2050 episode! @dave_bearss, CoFounder & CEO of @Halia_Tx, shares how they're leading the fight against Alzheimer’s w/ pioneering genetic discoveries & innovative therapies. Hosted by @rahulc Listen: on.soundcloud.com/Jn2APTDkoN… #BiotechPodcast #AlzheimersCure
2
126
Excited to have Ken Keller, President & CEO of @DaiichiSankyoUS, on #Biotech2050 with @rahulc! 🎙️ We discuss the future of cancer therapies, innovative ADCs, and insights into partnerships and team building. Listen to the episode: on.soundcloud.com/zGKkxeZehv… #Biotech #CancerResearch
2
5
276
It was great catching up with @Ptipirneni of @MorphicTx on the new episode of @Biotech2050Pod. Learn about his journey to being a first-time CEO, integrin #biology, the role of BD in #biopharma, and key drivers leading to the growing potential in the #autoimmune space.
Join @rahulc and Praveen Tipirneni, CEO of Morphic Therapeutic , as they delve into the future of autoimmune therapies and driving innovation in biotech. Don't miss this insightful discussion! #Biotech #AutoimmuneTherapies #Innovation Listen now: on.soundcloud.com/9ZTpn4UX7L…
3
151
I will be at #BIO2024 next week discussing industry innovations for @Biotech2050Pod and sharing how @meetclora is derisking #drugdevelopment by modernizing operating models and #hiring. If you'll be attending, let's meet! Send me a message to schedule time to connect.
4
127
Excited to share the latest @Biotech2050 episode with Robert Ang, CEO of @VorBio. We discussed his journey from #medicine to #VC to #entrepreneurship, next-gen #cancer therapies, and his approach to indication selection. Huge thanks to Robert for his insights!
Excited to have Robert Ang, CEO of Vor Bio, on the latest episode of #Biotech2050 hosted by @rahulc! 🎙️ Tune in as we discuss the future of cancer therapies. Don't miss out! #Biotech #CancerResearch #Innovation Listen to the episode: on.soundcloud.com/hYe86KvPRN…
5
369
Biotech faced big layoffs in Q1 of this year, with 57 companies affected, matching Q1 2023 but up 90% from 2022: ow.ly/WCeJ50RT3ac How are you navigating the current environment? What does the future of work in #biotech look like? Comment or message me.
4
145
Heading to #BIO2024 in San Diego in a few weeks! Excited to meet with industry leaders and discuss how @meetclora is solving some of the biggest challenges teams face today. Send me a message if you want to meet up!
1
5
105
Court rulings dismissed recent challenges by Bristol Myers Squibb & Johnson & Johnson against the US Inflation Reduction Act's pricing rules. This marks a defining moment for the future of drug development and healthcare advancements. ow.ly/gAWR50RIMEn
3
188
Rahul Chaturvedi retweeted
Excited to share the recent interview our CEO @rahulc and @aloktayi VP of Life Sciences at @Egnyte had with Stephan Kontos, Co-Founder and CSO at Anokion! #biotech #pharma #autoimmune #celiac bit.ly/2LsgdMt
Join @rahulc and @aloktayi as they speak with Stephan Kontos, Co-Founder and CSO at Anokion, to learn how he took his #PhD from @EPFL_en and became an #entrepreneur in #biotech. Great insights into emerging #autoimmune therapeutics for #celiac. bit.ly/2LsgdMt
2
8
Rahul Chaturvedi retweeted
We are excited to announce the launch of The Clora Blog, a resource dedicated to sharing insights on how to consult, build, and lead teams in the life science industry! Subscribe for new posts every week - hubs.ly/H0dnwjQ0
2
4
Rahul Chaturvedi retweeted
Because hiring life science consultants is faster and easier than ever, companies will be able to piece together the perfect team of experts with extreme agility. Here's how to assemble yours - hubs.ly/H0dnvZj0
2
2
Come join us at @MeetClora if you’re passionate about biopharma and tech.
8
Rahul Chaturvedi retweeted
Companies who use Clora to hire life science consultants save 70% of costs compared to those who use traditional recruiting methods. Learn more - hubs.ly/H0dd-Jv0 #lifescience #pharma #biotech #biopharma #recruiting #consulting
1
4
Thrilled to be in our new digs!
All settled into our new office in Downtown Boston. Also, excited to have @sallyraichu join our team!
1
7
Rahul Chaturvedi retweeted
To tame Type 2 diabetes, feed your inner beasts. Literally. buff.ly/2Fv54Gc
7
4